Bayesian Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bayesian Capital Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,300	Closed	-$284K	–	790
2025 Q1	$284K	Buy	+3,300	New	+$271K	0.05%	404
2024 Q4	–	Sell	-3,011	Closed	-$217K	–	908
2024 Q3	$217K	Buy	+3,011	New	+$213K	0.03%	549
2024 Q2	–	Sell	-2,939	Closed	-$213K	–	1000
2024 Q1	$213K	Buy	+2,939	New	+$197K	0.02%	644
2023 Q3	–	Sell	-3,575	Closed	-$212K	–	913
2023 Q2	$212K	Buy	+3,575	New	+$214K	0.02%	628
2022 Q3	–	Sell	-4,918	Closed	-$289K	–	946
2022 Q2	$289K	Buy	4,918 +100	+2%	+$5.51K	0.05%	495
2022 Q1	$255K	Buy	+4,818	New	+$278K	0.04%	575
2018 Q4	–	Sell	-15,132	Closed	-$573K	–	741
2018 Q3	$573K	Sell	15,132 -8,900	-37%	-$337K	0.09%	299
2018 Q2	$922K	Buy	+24,032	New	+$810K	0.21%	124
2017 Q2	–	Sell	-3,800	Closed	-$211K	–	555
2017 Q1	$211K	Buy	+3,800	New	+$210K	0.1%	335
2016 Q4	–	Sell	-11,976	Closed	-$578K	–	678
2016 Q3	$578K	Buy	+11,976	New	+$606K	0.38%	91

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bayesian Capital Management's PBH Position: Q2 2025 in Review

Bayesian Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2025, closing a stake of 3,300 shares — an estimated $284K sold.

Bayesian Capital Management first reported a position in PBH in Q3 2016 and held it in 10 quarters. The position peaked at $922K in Q2 2018. 378 funds tracked by Wall St. Rank hold PBH as of Q2 2025.

Bayesian Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2025 after selling out during the quarter.
Bayesian Capital Management sold 3,300 Prestige Consumer Healthcare shares in Q2 2025, an estimated $284K.
Bayesian Capital Management first reported a position in Prestige Consumer Healthcare in Q3 2016 and held it in 10 quarters.
Bayesian Capital Management's Prestige Consumer Healthcare position peaked at $922K in Q2 2018.
378 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.